ReproUnionReproductive Medicine Across Borders
When asking young people, most envision a life with children, but reproductive challenges affect up to 25% of couples in Scandinavia. Every 8th woman never becomes a mother, and every 5th man never becomes a father.
With a new research and innovation paradigm within reproductive medicine in the Øresund Region, ReproUnion wants to meet current and future demands of preventing, managing, and treating infertility. Infertility is recognized as a disease by the WHO, but despite revolutionary developments in the techniques for assisted reproduction, the success rate is still below 30%.
ReproUnion drives fertility collaboration across borders and disciplines between academia, hospitals, and industry. Our aim is to understand the underlying reasons of infertility and to personalise and improve fertility treatment. We also work on preventive initiatives to ensure that the society and young people are equipped with the right information to make informed choices about family planning.
Find out what’s going on & stay up to date
The Novo Nordisk Foundation grants DKK 10 mio to introduce genetics and personalised medicine for improved fertility treatment
With their RESPOND project, Professors Eva Hoffmann and Anja Pinborg have received DKK 10 million from the Novo Nordisk Foundation and its Tandem...
On the 8th of April 2021, Professor Eva Hoffmann was among the first presenters at the virtual ’Best of ASRM & ESHRE 2021’ conference with her...
The authors Søren Ziebe, Lone Schmidt and Sophie Hæstorp Andersen bring up a sensitive, yet necessary topic, since reproductive challenges also impact our welfare model.